Mechanical Cardiopulmonary Resuscitation During Treatment of Acute Respiratory Failure Through Extracorporeal Membrane Oxygenation.

Completed

• Conditions: Cardiovascular Resuscitation; Venovenous Extracorporeal Membrane Oxygenation

• Registration Number: NCT05342363
• Lead Sponsor: Goethe University

Brief Summary

In-hospital cardiovascular arrest is associated with poor outcome despite prompt treatment and optimal on-site resources. The population of patients treated by venovenous extracorporeal membrane oxygenation (vv-ECMO) due to pulmonary failure is a very challenging group of patients. To date, the frequency, causes and outcome of cardiovascular arrest in these patients have not been studied. We are aiming to conduct a retrospective observational study of all vv-ECMO patients treated at our ARDS centre.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2022-04-16
• Study First Submitted QC: 2022-04-16
• Study First Posted: 2022-04-22
• Study Start: 2022-06-01
• Primary Completion: 2023-05-01
• Status Verified: 2023-08
• Study Completion: 2023-08-01
• Last Update Submitted: 2023-08-28
• Last Update Posted: 2023-08-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

Patients treated with veno-venous extracorporeal membrane oxygenation (vv-ECMO) due to respiratory failure during acute respiratory distress syndrome (ARDS).

Exclusion Criteria

Patients treated with veno-arterial extracorporeal membrane oxygenation (va-ECMO)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Survival of mechanical cardiovascular resuscitation	During the intensive care stay ( usually between 2 and 8 weeks)	Survival of mechanical cardiovascular resuscitation

Secondary Outcome Measures

Name	Time	Method
Incidence of cardiovascular resuscitation i	During the observation period 2019-2022	Incidence of cardiovascular resuscitation in patients treated with venovenous extracorporeal membrane oxygenation.
Complications of resuscitation treatments	During the intensive care stay ( usually between 2 and 8 weeks)	Complications of cardiovascular resuscitation in patients treated with venovenous extracorporeal membrane oxygenation

Trial Locations

Locations (1)

University Hospital Frankfurt; 🇩🇪 Frankfurt, Hessen, Germany